Detalhe da pesquisa
1.
Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals.
Clin Infect Dis
; 77(6): 910-916, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337899
2.
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
Vaccine
; 40(36): 5347-5355, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933278
3.
Purified Vero Cell Rabies Vaccine (PVRV, Verorab®): A Systematic Review of Intradermal Use Between 1985 and 2019.
Trop Med Infect Dis
; 5(1)2020 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156005
4.
Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.
Vaccine
; 38(21): 3740-3746, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32280042
5.
Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
Vaccine
; 37(16): 2268-2277, 2019 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890382
6.
Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study.
Int J Infect Dis
; 66: 137-142, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29081368
7.
A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants.
Jpn J Infect Dis
; 71(6): 402-407, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29962480
8.
Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months.
Indian Pediatr
; 55(12): 1050-1055, 2018 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745476
9.
Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil.
PLoS Negl Trop Dis
; 10(9): e0004920, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27653947
10.
Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
Pediatr Infect Dis J
; 35(2): e60-4, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26535878
11.
A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
Vaccine
; 33(48): 6697-702, 2015 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26518404
12.
Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.
Vaccine
; 32(43): 5715-21, 2014 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25151042
13.
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Hum Vaccin Immunother
; 10(9): 2656-63, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483480
14.
Safety and immunogenicity of a meningococcal quadrivalent conjugate vaccine in five- to eight-year-old Saudi Arabian children previously vaccinated with two doses of a meningococcal quadrivalent polysaccharide vaccine.
Clin Vaccine Immunol
; 19(10): 1561-6, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22855388
15.
Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, and modified blind-observer study.
Clin Vaccine Immunol
; 19(7): 999-1004, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22552602